Cetera Investment Advisers
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1666741
SCHAUMBURG, IL
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,366,875
+$165,155 QoQ
Shares Held
16,006
+1.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Mar 31, 2026CallValue
$77,264
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $158,169,500 across 104 Biotechnology names. REGN ranks #2 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
72,633 | $32,433,539 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
16,006 | $12,366,875 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,173 | $7,667,250 | |
| 4 | EXEL |
Exelixis, Inc.
|
169,881 | $7,286,196 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
946,709 | $7,261,258 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
764,615 | $6,476,289 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
189,028 | $6,150,971 | |
| 8 | INSM |
INSMED Inc
|
34,356 | $5,617,893 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,264 | 100 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $12,366,875 | 16,006 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,201,720 | 15,808 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,023,871 | 16,049 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,120,850 | 9,754 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,706,982 | 10,575 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,581,216 | 9,239 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,193,093 | 8,745 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,351,484 | 7,946 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $9,387,164 | 9,753 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $3,335,745 | 3,798 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,028,492 | 3,680 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,726,140 | 3,794 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,043,465 | 3,704 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,305,160 | 3,195 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $980,950 | 1,424 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,619,105 | 2,739 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,109,926 | 3,021 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,946,976 | 3,083 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,587,992 | 2,624 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,435,447 | 2,570 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,305,393 | 2,759 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,099,558 | 2,276 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||